REFRACTORY KAPOSI SARCOMA

Clinical trials for REFRACTORY KAPOSI SARCOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY KAPOSI SARCOMA trials appear

Sign up with your email to follow new studies for REFRACTORY KAPOSI SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Two-Pronged attack tested for stubborn skin cancer

Disease control Terminated

This study aimed to test a combination of two drugs, pembrolizumab and lenvatinib, for adults with classic Kaposi sarcoma that had come back or stopped responding to prior chemotherapy. The goal was to see if this two-drug approach could shrink tumors and control the disease bett…

Matched conditions: REFRACTORY KAPOSI SARCOMA

Phase: PHASE2 • Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

REFRACTORY KAPOSI SARCOMA

Get alerted when new REFRACTORY KAPOSI SARCOMA trials appear

Two-Pronged attack tested for stubborn skin cancer